Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Study Evaluating the Efficacy of the Vielight RX Plus in the Treatment of COVID-19 Respiratory Symptoms

NCT04418505 is registered in ClinicalTrials.gov with Vielight Inc. as lead sponsor.

NCT NCT04418505
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04418505 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Study Evaluating the Efficacy of the Vielight RX Plus in the Treatment of COVID-19 Respiratory Symptoms
Lead sponsor
Vielight Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
September 2, 2020
Completion date
September 30, 2021
Enrollment
295 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19